Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
doxepin hydrochloride, Quantity: 28.25 mg (Equivalent: doxepin, Qty 25 mg)
Alphapharm Pty Ltd
Capsule, hard
Excipient Ingredients: purified talc; sodium starch glycollate; titanium dioxide; Gelatin; lactose monohydrate; colloidal anhydrous silica; brilliant blue FCF; erythrosine; sodium lauryl sulfate; magnesium stearate
Oral
10 (sample), 1000, 50, 90
Medicine Registered
(S4) Prescription Only Medicine
For the treatment of major depression.
Visual Identification: Size 3 capsule with white body and blue cap; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
1997-07-02
DEPTRAN _doxepin (as hydrochloride)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about DEPTRAN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking DEPTRAN against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT DEPTRAN IS USED FOR DEPTRAN is used to treat depression. DEPTRAN 10 mg and DEPTRAN25 mg capsules can be used at any stage in the treatment of depression. However, the higher strength, DEPTRAN50 mg tablets, is approved only for the maintenance treatment of depression (after your symptoms have improved). DEPTRAN belongs to a group of medicines called tricyclic antidepressants (TCAs). Antidepressants are thought to work by their action on brain chemicals called amines which are involved in controlling mood. Your doctor, however, may prescribe DEPTRAN for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY DEPTRAN HAS BEEN PRESCRIBED FOR YOU. This medicine is only available with a doctor's prescription. DEPTRAN should not be used in children and adolescents under the age of 18 years. The safety and effectiveness of DEPTRAN in this age group has not been satisfactorily established. BEFORE YOU TAKE DEPTRAN _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE DEPTRAN IF YOU HAVE AN ALLERGY TO: • any medicine containing doxepin hydrochloride • any other tricyclic antidepressants such as amitriptyline and imipramine • any of the ingredients listed at the end of this leaflet. Symptoms of an allergic reaction to DEPTRAN may include: • shortness of breath • wheezing or difficulty breathing • skin rash, itching or hives on the skin • swelling of the face, lips, tongue or other parts of the body • increased sensitivity of the skin to the sun. D Đọc toàn bộ tài liệu
AUSTRALIAN PRODUCT INFORMATION DEPTRAN _doxepin (as hydrochloride) _ 1 NAME OF THE MEDICINE Doxepin (as hydrochloride) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Doxepin hydrochloride, a dibenzoxepin derivative, consists of a mixture of the _cis-_ and _trans-_ isomers in a constant ratio (13 to 18.5% _cis_ ; 87 to 81.5% _trans_ ). Each capsule contains either 10 mg or 25 mg of doxepin (as hydrochloride) as the active ingredient. Each tablet contains either 50 mg or 75 mg of doxepin (as hydrochloride) as the active ingredient. Excipients with known effect: sugars (as lactose), galactose and sulfites. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Doxepin is a white, crystalline powder, with a slight and amine-like odour. It is soluble in 1.5 parts of water, in 1 part of ethanol (96%) and in 2 parts of chloroform, and has a melting point of 185°-191°. DEPTRAN 10: size 3 capsule with a white opaque body and white opaque cap with “DP 10” printed in black ink. DEPTRAN 25: size 3 capsule with a white opaque body and blue cap. DEPTRAN 50: violet film coated, hexagonal tablet, marked "DN" over "50" on one side and "α" on reverse. DEPTRAN 75: white film coated, hexagonal tablet, marked "DN" break line "75" on one side and "α" on reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of major depression. The 50 mg and 75 mg tablets are indicated only for the maintenance treatment of major depression (see section 4.4 Special Warnings and Precautions for Use). 4.2 DOSE AND METHOD OF ADMINISTRATION The optimum oral dose depends on the severity of the condition and the individual patient's response. The dose varies from 30 mg to 300 mg daily, and is usually administered in a three times daily regimen. When the optimum dose has been reached, it may be given as a single daily dose up to a maximum of 150 mg. _For patients where the presenting symptoms are mild_ , it is advisable to initiate treatment at a dose of 30 mg daily; a good clinical response is ob Đọc toàn bộ tài liệu